

²úÆ·ÐͺţºPC0308
²Î¿¼¼Û¸ñ£º1700
¸üÐÂʱ¼ä£º2026-06-02
·Ã ÎÊ Á¿£º18
²úÆ··ÖÀà
CLASSIFICATION
Ïà¹ØÎÄÕÂ
RELATED ARTICLES2025-07-11
2025-06-11
2025-06-06
2025-06-05
2026-05-19
2025-06-24
2026-01-30
2025-12-23
2025-03-10
2025-02-17
Ïêϸ½éÉÜ
LDLÊÇÓɼ«µÍÃܶÈÖ¬µ°°×£¨VLDL£©×ª±ä¶øÀ´£¬Ö÷Òª¹¦ÄÜÊǰѵ¨-¹Ì´¼ÔËÊ䵽ȫÉí¸÷´¦Ï¸°û£¬ÔËÊäµ½¸ÎÔàºÏ³Éµ¨ËᣬÆä¿ÉÓÃÓÚÑо¿ÊÜÌå½éµ¼µÄÄÚÍÌ×÷Óùý³Ì£¬ÓÈÆäÊÇÔÚ¶¯ÂöÖàÑùÓ²»¯µÈ¼²²¡ÖУ¬ÆäѪ½¬À´Ô´µÄLDL¿ÉÓÃÓÚÑо¿LDLÔÚ¹¦ÄܺʹúлÖеÄÑõ»¯×÷Óá£
ÒÒõ£»¯µÄLDLÊÇÐÞÊÎLDLÖеÄÒ»À࣬LDLº¬ÓÐδÐÞÊεÄÔØÖ¬µ°°×£¬¿ÉÒÔÓÃÀ´Ñо¿Õý³£µ¨-¹Ì´¼µÄתÔ˺ÍÄÚÍÌ×÷Óᣵ±LDLÔØÖ¬µ°°×µÄÀµ°±Ëá²Ð»ù±»ÒÒõ£»¯ÐÞÊκó£¬LDL¸´ºÏÎï²»ÔÙÓëLDLÊÜÌå½áºÏ£¬µ«ÊÇ£¬ÐÞÊÎÐÍLDL¸üÈÝÒ×ÓëÄÚÆ¤Ï¸°ûºÍС½ºÖÊÉñ¾Ï¸°ûµÄ¡°scavenger"ÊÜÌå½áºÏ¡£Òò´Ë£¬Ac-LDL¿ÉÓÃÀ´Ñо¿ÉÏÊöϸ°ûµÄ¹¦ÄÜ¡£
ÈËÔ´ÒÒõ£»¯µÍÃܶÈÖ¬µ°°×£¨Human Acetylated Low Density Lipoprotein, Human Ac-LDL£©£¬À´×Ô½¡¿µÈËԴѪ½¬LDL£¬Hepatitis C£¬HIV-IºÍHIV-II¿¹Ìå¼ì²â¾ùΪÒõÐÔ¡£µ±DiO-Ac-LDL±ê¼Çϸ°ûºó£¬ÔÚÈÜøÌåøµÄ×÷ÓÃÏ£¬Ö¬µ°°×±»½µ½â£¬¶øDiOÔÚϸ°ûÄÚĤ¾Û¼¯£¬´Ó¶ø¿ÉÒÔÓÃÀ´¼ì²âÐÞÊÎÐÍLDLµÄÎüÊÕÇé¿ö¡£¿ÉÒÔÓÃÀ´±ê¼ÇѪ¹ÜÄÚÆ¤Ï¸°û¡¢¾ÞÊÉϸ°ûºÍÄÚÆ¤×æÏ¸°û£¨EPC£©£¬¿ÉÓÃÀ´¼ø¶¨²¢·ÖÑ¡ÕâЩϸ°û£¬ÒÔ¼°ÓÃÀ´Ñо¿²»Í¬Ï¸°ûϵ¶ÔÐÞÊλ¯LDLµÄÄÚÍÌ×÷Óá£ÎÒ˾ÌṩµÄDiO-Ac-LDL£¬Ã¿¸öÅú´Î¾ù¾¹ýÅ£´ó¶¯ÂöÄÚÆ¤Ï¸°ûºÍСÊó¾ÞÊÉϸ°ûµÄ±ê¼Ç¼ì²âÀ´ÆÀ¹À²úÆ·µÄ±ê¼ÇÌØÒìÐÔ£¬´Ó¶ø±£Ö¤½á¹ûµÄÒ»ÖÂÐÔ¡£
±¾Æ·ÎªÂÌɫӫ¹â±ê¼ÇµÄÒÒõ£»¯ÈËÔ´µÍÃܶÈÖ¬µ°°×£¨Human DiO-Ac-LDL£©ÎªÎÞ¾ú°ü×°£¬¿ÉÒÔÖ±½ÓÏ¡ÊÍʹÓᣳýÌṩHuman DiO-Ac-LDL£¬ÎÒÃÇ»¹Ìṩ²»´ø±ê¼ÇµÄAc-LDL£¬Ox-LDL£¨Ñõ»¯ÐÞÊΣ©ÒÔ¼°²»¾ÐÞÊεÄLDLµÈ¡£
²úÆ·ÊôÐÔ
´¿¶È£º£¾98%
Ũ¶È£º0.8-3.0 mg/ml
Íâ¹Û£ºÈé×´ÒºÌå
»º³åÒº×é·Ö£º0.02 mM EDTA in PBS, pH 7.4
ÔËÊäÓë±£´æ·½·¨£º±ù´üÔËÊä¡£4¡æ±£´æ£¬½¨Òé±Ü¹â£¬6ÖÜÎȶ¨¡£Ç§Íò²»¿É¶³´æ£¡£¡
ʵÑé²½Öè
1. ÔÚÉú³¤ÅàÑø»ùÖн«DiO-Ac-LDLÏ¡ÊÍÖÁ20-50ug/ml£»
2. ½«Æä¼ÓÈ뵽ϸ°ûÖÐ37 ?CÎÂÓý4Сʱ£»
3. È¥µôÅàÑø»ù£»
4. ÓÃÎÞ̽ÕëµÄ»º³åÒº³åÏ´£»
5. ͨ¹ýÓ«¹âÏÔ΢¾µ¹Û²ì²¢/»òÕß½«Ï¸°ûͨ¹ýÒÈ-µ°°×ø£¨»òÕßEDTA£©½øÐзÖÀà¡£
6. Ó«¹âÏÔ΢¾µ£ºÓñê×¼FITC¼¤·¢½øÐÐ¹Û²ì £¨»òÕß½¨ÒéÓò¨³¤¼¤·¢£º484nm¡¢·¢É䣺501nm£©¡£Èç¹ûÐèÒª£¬ÓÃ3%¼×È©ÔÚPBSÖй̶¨¡£ÇÐÎðʹÓü״¼»ò±ûͪ½øÐй̶¨£¬ÒòΪDiOÈÜÓÚÓлúÈܼÁ¡£
×¢ÒâÊÂÏî
1£©±¾Æ·µÄÏ¡Ê͹¤×÷Òº¼«²»Îȶ¨£¬½¨Òé¼´Åä¼´Óã»
2£©³¤ÆÚÖü´æ¿ÉÄÜ»áÓгÁµíÎö³ö£¬ÊôÓÚÕý³£ÏÖÏ󣬵ÍËÙÀëÐÄ2 minÈ¥³ý³Áµí¼´¿ÉʹÓã»
3£©ÎªÁËÄúµÄ°²È«ºÍ½¡¿µ£¬Ç봩ʵÑé·þ²¢´÷Ò»´ÎÐÔÊÖÌײÙ×÷¡£
²úÆ·×Éѯ